Search Results

Cognitive enhancement as a pharmacotherapy target for stimulant addiction

Author: Sofuoglu, Mehmet

Source: Addiction, Volume 105, Number 1, January 2010 , pp. 38-48(11)

Publisher: Blackwell Publishing

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†

Authors: Garnock-Jones, Karly P.; Keating, Gillian M.

Source: CNS Drugs, Volume 24, Number 1, 1 January 2010 , pp. 85-88(4)

Publisher: Adis International

Attention-Deficit Hyperactivity Disorder: Recent Advances in Paediatric Pharmacotherapy

Authors: May, Diane E.; Kratochvil, Christopher J.

Source: Drugs, Volume 70, Number 1, 1 January 2010 , pp. 15-40(26)

Publisher: Adis International

Atomoxetine Attenuates Dextroamphetamine Effects in Humans

Authors: Sofuoglu, Mehmet; Poling, James; Hill, Kevin; Kosten, Thomas

Source: The American Journal of Drug and Alcohol Abuse, Volume 35, Number 6, December 2009 , pp. 412-416(5)

Publisher: Informa Healthcare

Differential inhibitory effects of drugs acting at the noradrenaline and 5-hydroxytryptamine transporters in rat and human neocortical synaptosomes

Authors: Mantovani, M; Dooley, DJ; Weyerbrock, A; Jackisch, R; Feuerstein, TJ

Source: British Journal of Pharmacology, Volume 158, Number 7, December 2009 , pp. 1848-1856(9)

Publisher: Blackwell Publishing

Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations

Authors: Hamoda, Hesham M; Guild, Danielle J; Gumlak, Sarah; Travers, Brian H; Gonzalez-Heydrich, Joseph

Source: Expert Review of Neurotherapeutics, Volume 9, Number 12, December 2009 , pp. 1747-1754(8)

Publisher: Expert Reviews

Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder

Authors: Montoya, Alonso; Hervas, Amaia; Cardo, Esther; Artigas, Josep; Mardomingo, María J.; Alda, José A.; Gastaminza, Xavier; García-Polavieja, María J.; Gilaberte, Inmaculada; Escobar, Rodrigo

Source: Current Medical Research and Opinion, Volume 25, Number 11, November 2009 , pp. 2745-2754(10)

Publisher: Informa Healthcare

Atomoxetine: Transient psychosis: case report

Source: Reactions, Volume 1, Number 1270, 2009-09-19 , pp. 9-9(1)

Publisher: Adis International

Sibutramine overdose: Multiple toxicities, including those due to interactions with atomoxetine, methylphenidate and citalopram: 17 case reports

Source: Reactions, Volume 1, Number 1271, 2009-09-26 , pp. 30-30(1)

Publisher: Adis International

Atomoxetine/methylphenidate: Spontaneous ejaculation: 2 case reports

Source: Reactions, Volume 1, Number 1272, 2009-10-03 , pp. 9-9(1)

Publisher: Adis International

News from ICPE

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 4-5(2)

Publisher: Adis International

Mortality Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment: A Retrospective Cohort Study of Children, Adolescents and Young Adults Using the General Practice Research Database

Authors: McCarthy, Suzanne; Cranswick, Noel; Potts, Laura; Taylor, Eric; Wong, Ian C.K.

Source: Drug Safety, Volume 32, Number 11, 1 November 2009 , pp. 1089-1096(8)

Publisher: Adis International

Retrospective Safety Analysis of Atomoxetine in Adult ADHD Patients with or without Comorbid Alcohol Abuse and Dependence

Authors: Adler, Lenard; Wilens, Timothy; Zhang, Shuyu; Durell, Todd; Walker, Daniel; Schuh, Leslie; Jin, Ling; Feldman, Peter; Trzepacz, Paula

Source: American Journal on Addictions, Volume 18, Number 5, September 2009 , pp. 393-401(9)

Publisher: Informa Healthcare

Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions

Authors: Dell'Agnello, Grazia; Zuddas, Alessandro; Masi, Gabriele; Curatolo, Paolo; Besana, Dante; Rossi, Andrea

Source: CNS Drugs, Volume 23, Number 9, 1 September 2009 , pp. 739-753(15)

Publisher: Adis International

A statewide second opinion process implemented in Washington, US, reduced outlier attention-deficit hyperactivity disorder (ADHD) medication prescription practices

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 585, 2009-08-22 , pp. 6-6(1)

Publisher: Adis International

Atomoxetine cost-effective in ADHD

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 584, 2009-08-08 , pp. 4-4(1)

Publisher: Adis International

Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults

Author: Wigal, Sharon B.

Source: CNS Drugs, Volume 23, Supplement 1, 1 September 2009 , pp. 21-31(11)

Publisher: Adis International

Toward a New Understanding of Attention-Deficit Hyperactivity Disorder Pathophysiology: An Important Role for Prefrontal Cortex Dysfunction

Author: Arnsten, Amy F.T.

Source: CNS Drugs, Volume 23, Supplement 1, 1 September 2009 , pp. 33-41(9)

Publisher: Adis International

Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK

Authors: Prasad, S.; Arellano, J.; Steer, C.; Libretto, S. E.

Source: International Journal of Clinical Practice, Volume 63, Number 7, July 2009 , pp. 1031-1040(10)

Publisher: Blackwell Publishing

The Norwegian Medicines Agency has received 10 reports of hallucinations and/or psychosis associated with methylphenidate.

Source: Reactions, Volume 1, Number 1253, 2009-05-23 , pp. 2-2(1)

Publisher: Adis International